Nipah Virus-Another Threat From the World of Zoonotic Viruses

Among the diseases that pose a serious threat to public health, those caused by viruses are of great importance. The Nipah virus (NiV) belonging to the family was reported in Malaysia in 1998/1999. Due to its high mortality in humans, its zoonotic nature, the possibility of human-to-human transmissi...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2022-01, Vol.12, p.811157-811157
Main Authors: Skowron, Krzysztof, Bauza-Kaszewska, Justyna, Grudlewska-Buda, Katarzyna, Wiktorczyk-Kapischke, Natalia, Zacharski, Maciej, Bernaciak, Zuzanna, Gospodarek-Komkowska, Eugenia
Format: Article
Language:English
Subjects:
diagnosis
epidemics
health treat
Microbiology
Nipah
transmission routes
vaccine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Among the diseases that pose a serious threat to public health, those caused by viruses are of great importance. The Nipah virus (NiV) belonging to the family was reported in Malaysia in 1998/1999. Due to its high mortality in humans, its zoonotic nature, the possibility of human-to-human transmission, and the lack of an available vaccine, the World Health Organization (WHO) has recognized it as a global health problem. Depending on strain specificity, neurological symptoms and severe respiratory disorders are observed in NiV infection. In most confirmed cases of NiV epidemics, the appearance of the virus in humans was associated with the presence of various animal species, but generally, bats of species are considered the most important natural animal NiV reservoir and vector. Consumption of contaminated food, contact with animals, and "human-to-human" direct contact were identified as NiV transmission routes. Due to the lack of vaccines and drugs with proven effectiveness against NiV, treatment of patients is limited to supportive and prophylactic.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2021.811157